{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T05:49:51Z","timestamp":1781934591661,"version":"3.54.5"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32160215"],"award-info":[{"award-number":["32160215"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.neuropharm.2026.110887","type":"journal-article","created":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T07:40:14Z","timestamp":1772264414000},"page":"110887","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Fisetin targets multiple signaling pathways to suppress microglia-mediated neuroinflammation and cognitive decline in Alzheimer's disease"],"prefix":"10.1016","volume":"290","author":[{"given":"Yu-Ting","family":"Dai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-Dong","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han-Dan","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Yi","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie-Lin","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Chen","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao-Ren","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8185-3130","authenticated-orcid":false,"given":"Jing-Ming","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2026.110887_bib1","doi-asserted-by":"crossref","DOI":"10.3390\/biom10010137","article-title":"Microglia mediated neuroinflammation: focus on PI3K modulation","volume":"10","author":"Cianciulli","year":"2020","journal-title":"Biomolecules"},{"key":"10.1016\/j.neuropharm.2026.110887_bib2","doi-asserted-by":"crossref","DOI":"10.3389\/fragi.2023.1231706","article-title":"The dual face of microglia (M1\/M2) as a potential target in the protective effect of nutraceuticals against neurodegenerative diseases","volume":"4","author":"Darwish","year":"2023","journal-title":"Frontiers in Aging"},{"key":"10.1016\/j.neuropharm.2026.110887_bib3","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1111\/bpa.12456","article-title":"Microglia show altered morphology and reduced arborization in human brain during aging and alzheimer's disease","volume":"27","author":"Davies","year":"2017","journal-title":"Brain Pathol."},{"key":"10.1016\/j.neuropharm.2026.110887_bib4","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.cell.2015.12.056","article-title":"The cellular phase of Alzheimer's Disease","volume":"164","author":"De Strooper","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.neuropharm.2026.110887_bib5","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1038\/s41467-021-22301-1","article-title":"Loss of microglial SIRP\u03b1 promotes synaptic pruning in preclinical models of neurodegeneration","volume":"12","author":"Ding","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neuropharm.2026.110887_bib6","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/s41392-023-01588-0","article-title":"Microglia in neurodegenerative diseases: mechanism and potential therapeutic targets","volume":"8","author":"Gao","year":"2023","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.neuropharm.2026.110887_bib7","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.nbd.2006.08.017","article-title":"Characterization of amyloid deposition in the APPswe\/PS1dE9 mouse model of alzheimer disease","volume":"24","author":"Garcia-Alloza","year":"2006","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuropharm.2026.110887_bib8","doi-asserted-by":"crossref","first-page":"10417","DOI":"10.1073\/pnas.1834302100","article-title":"Alzheimer's disease-affected brain: presence of oligomeric A beta ligands (ADDLs) suggests a molecular basis for reversible memory loss","volume":"100","author":"Gong","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2026.110887_bib9","doi-asserted-by":"crossref","first-page":"353","DOI":"10.3892\/mmr.2022.12869","article-title":"Increased expression of TSPO-VDAC complex is correlated with NLRP3 inflammasome activation in diabetic retinopathy","volume":"26","author":"Guo","year":"2022","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.neuropharm.2026.110887_bib10","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.chembiol.2020.12.001","article-title":"Recent advances in identifying protein targets in drug discovery","volume":"28","author":"Ha","year":"2021","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.neuropharm.2026.110887_bib11","article-title":"The neuroprotective effects of fisetin, a natural flavonoid in neurodegenerative diseases: focus on the role of oxidative stress","volume":"13","author":"Hassan","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.neuropharm.2026.110887_bib12","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1126\/science.aad8373","article-title":"Complement and microglia mediate early synapse loss in Alzheimer mouse models","volume":"352","author":"Hong","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2026.110887_bib13","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s12974-016-0543-5","article-title":"6-Mercaptopurine attenuates tumor necrosis factor-\u03b1 production in microglia through Nur77-mediated transrepression and PI3K\/Akt\/mTOR signaling-mediated translational regulation","volume":"13","author":"Huang","year":"2016","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.neuropharm.2026.110887_bib14","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1038\/nprot.2010.72","article-title":"Preparation and characterization of toxic Abeta aggregates for structural and functional studies in Alzheimer's disease research","volume":"5","author":"Jan","year":"2010","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.neuropharm.2026.110887_bib15","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1186\/s12974-022-02637-1","article-title":"Microglia dynamics in aging-related neurobehavioral and neuroinflammatory diseases","volume":"19","author":"Javanmehr","year":"2022","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.neuropharm.2026.110887_bib16","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1038\/cdd.2013.180","article-title":"Microglia convert aggregated amyloid-\u03b2 into neurotoxic forms through the shedding of microvesicles","volume":"21","author":"Joshi","year":"2014","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.neuropharm.2026.110887_bib17","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/s41572-021-00269-y","article-title":"Alzheimer disease","volume":"7","author":"Knopman","year":"2021","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.neuropharm.2026.110887_bib18","doi-asserted-by":"crossref","first-page":"10191","DOI":"10.1523\/JNEUROSCI.3432-04.2004","article-title":"Synaptic targeting by alzheimer's-related amyloid beta oligomers","volume":"24","author":"Lacor","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.110887_bib19","doi-asserted-by":"crossref","first-page":"6448","DOI":"10.1073\/pnas.95.11.6448","article-title":"Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins","volume":"95","author":"Lambert","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2026.110887_bib20","doi-asserted-by":"crossref","first-page":"9319","DOI":"10.1523\/JNEUROSCI.3246-05.2005","article-title":"Amyloid plaques and amyloid-beta oligomers: an ongoing debate","volume":"25","author":"Lesn\u00e9","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.110887_bib21","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.bbi.2020.10.007","article-title":"Role of astroglial toll-like receptors (TLRs) in central nervous system infections, injury and neurodegenerative diseases","volume":"91","author":"Li","year":"2021","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.neuropharm.2026.110887_bib22","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1186\/s12974-022-02613-9","article-title":"Mitochondrial dysfunction in microglia: a novel perspective for pathogenesis of Alzheimer's disease","volume":"19","author":"Li","year":"2022","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.neuropharm.2026.110887_bib23","doi-asserted-by":"crossref","first-page":"3693","DOI":"10.1074\/jbc.M110.135244","article-title":"Amyloid-beta protein oligomer at low nanomolar concentrations activates microglia and induces microglial neurotoxicity","volume":"286","author":"Maezawa","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2026.110887_bib24","doi-asserted-by":"crossref","first-page":"58","DOI":"10.2741\/s425","article-title":"How fisetin reduces the impact of age and disease on CNS function","volume":"7","author":"Maher","year":"2015","journal-title":"Front Biosci (Schol Ed)"},{"key":"10.1016\/j.neuropharm.2026.110887_bib25","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.3965","article-title":"Immunofluorescence characterization of spinal cord dorsal horn microglia and astrocytes in horses","volume":"5","author":"Meneses","year":"2017","journal-title":"PeerJ"},{"key":"10.1016\/j.neuropharm.2026.110887_bib26","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s13024-025-00867-4","article-title":"Biomarkers and therapeutic strategies targeting microglia in neurodegenerative diseases: current status and future directions","volume":"20","author":"Noh","year":"2025","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.neuropharm.2026.110887_bib27","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/php.12337","article-title":"Fisetin inhibits UVB-induced cutaneous inflammation and activation of PI3K\/AKT\/NF\u03baB signaling pathways in SKH-1 hairless mice","volume":"91","author":"Pal","year":"2015","journal-title":"Photochem. Photobiol."},{"key":"10.1016\/j.neuropharm.2026.110887_bib28","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aau6328","article-title":"Sodium rutin ameliorates Alzheimer's disease-like pathology by enhancing microglial amyloid-\u03b2 clearance","volume":"5","author":"Pan","year":"2019","journal-title":"Sci. Adv."},{"key":"10.1016\/j.neuropharm.2026.110887_bib29","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2013.503","article-title":"Oligomeric amyloid \u03b2 induces IL-1\u03b2 processing via production of ROS: implication in Alzheimer's disease","volume":"4","author":"Parajuli","year":"2013","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.neuropharm.2026.110887_bib30","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1021\/acschemneuro.2c00276","article-title":"Rationally designed molecules synergistically modulate multifaceted abeta toxicity, microglial activation, and neuroinflammation","volume":"13","author":"Ramesh","year":"2022","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.110887_bib31","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s13024-018-0254-8","article-title":"Identification and therapeutic modulation of a pro-inflammatory subset of disease-associated-microglia in Alzheimer's disease","volume":"13","author":"Rangaraju","year":"2018","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.neuropharm.2026.110887_bib32","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1002\/ana.26465","article-title":"Microglial activation and connectivity in alzheimer disease and aging","volume":"92","author":"Rauchmann","year":"2022","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuropharm.2026.110887_bib33","doi-asserted-by":"crossref","first-page":"858","DOI":"10.3109\/08923973.2012.665461","article-title":"The PI3K\/Akt pathway is required for LPS activation of microglial cells","volume":"34","author":"Saponaro","year":"2012","journal-title":"Immunopharmacol. Immunotoxicol."},{"key":"10.1016\/j.neuropharm.2026.110887_bib34","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/978-1-0716-3786-9_15","article-title":"Detection of induction of mitochondrial oxidative stress by nanoparticles in T cells using MitoSOX red dye","volume":"2789","author":"Shah","year":"2024","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.neuropharm.2026.110887_bib35","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/1742-2094-8-117","article-title":"Sinomenine inhibits microglial activation by A\u03b2 and confers neuroprotection","volume":"8","author":"Shukla","year":"2011","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.neuropharm.2026.110887_bib36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1742-2094-6-1","article-title":"Beta amyloid oligomers and fibrils stimulate differential activation of primary microglia","volume":"6","author":"Sondag","year":"2009","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.neuropharm.2026.110887_bib37","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/1742-2094-8-92","article-title":"TLR4 mutation reduces microglial activation, increases A\u03b2 deposits and exacerbates cognitive deficits in a mouse model of Alzheimer's disease","volume":"8","author":"Song","year":"2011","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.neuropharm.2026.110887_bib38","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jalz.2011.03.003","article-title":"Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National institute on aging-alzheimer's association workgroups on diagnostic guidelines for Alzheimer's disease","volume":"7","author":"Sperling","year":"2011","journal-title":"Alzheimer's Dement."},{"key":"10.1016\/j.neuropharm.2026.110887_bib39","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s00018-025-05873-9","article-title":"Rhapontigenin attenuates neurodegeneration in a Parkinson'S disease model by downregulating mtDNA-cGAS-STING-NF-\u03baB-mediated neuroinflammation via PINK1\/DRP1-dependent microglial mitophagy","volume":"82","author":"Su","year":"2025","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.neuropharm.2026.110887_bib40","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s12896-023-00815-4","article-title":"Target identification of small molecules: an overview of the current applications in drug discovery","volume":"23","author":"Tabana","year":"2023","journal-title":"BMC Biotechnol."},{"key":"10.1016\/j.neuropharm.2026.110887_bib41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10753-022-01721-1","article-title":"Neuroinflammation in Alzheimer's Disease: current progress in molecular signaling and therapeutics","volume":"46","author":"Thakur","year":"2023","journal-title":"Inflammation"},{"key":"10.1016\/j.neuropharm.2026.110887_bib42","doi-asserted-by":"crossref","DOI":"10.1126\/science.ady3217","article-title":"Predicting and preventing Alzheimer's disease","volume":"388","author":"Topol","year":"2025","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2026.110887_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2022.101622","article-title":"Glial cells in Alzheimer's disease: from neuropathological changes to therapeutic implications","volume":"78","author":"Uddin","year":"2022","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.neuropharm.2026.110887_bib44","doi-asserted-by":"crossref","first-page":"3487","DOI":"10.1007\/s10753-025-02279-4","article-title":"4,4'-Dimethoxychalcone mitigates neuroinflammation following traumatic brain injury through modulation of the TREM2\/PI3K\/AKT\/NF-\u03baB signaling pathway","volume":"48","author":"Wang","year":"2025","journal-title":"Inflammation"},{"key":"10.1016\/j.neuropharm.2026.110887_bib45","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.intimp.2015.03.013","article-title":"Thymoquinone inhibits lipopolysaccharide-induced inflammatory mediators in BV2 microglial cells","volume":"26","author":"Wang","year":"2015","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.neuropharm.2026.110887_bib46","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1742-2094-3-30","article-title":"The microglial NADPH oxidase complex as a source of oxidative stress in Alzheimer's disease","volume":"3","author":"Wilkinson","year":"2006","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.neuropharm.2026.110887_bib47","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.jep.2018.02.025","article-title":"Piper sarmentosum Roxb. confers neuroprotection on beta-amyloid (A\u03b2)-induced microglia-mediated neuroinflammation and attenuates tau hyperphosphorylation in SH-SY5Y cells","volume":"217","author":"Yeo","year":"2018","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.neuropharm.2026.110887_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainresbull.2024.111008","article-title":"Activation of pyramidal neurons in the infralimbic cortex alleviates LPS-induced depressive-like behavior in mice","volume":"214","author":"Zhang","year":"2024","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.neuropharm.2026.110887_bib49","doi-asserted-by":"crossref","first-page":"7235","DOI":"10.2147\/JIR.S483412","article-title":"Prevention and treatment strategies for Alzheimer's Disease: focusing on microglia and astrocytes in neuroinflammation","volume":"17","author":"Zhang","year":"2024","journal-title":"J. Inflamm. Res."},{"key":"10.1016\/j.neuropharm.2026.110887_bib50","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1016\/j.biopha.2016.08.035","article-title":"Fisetin inhibits laryngeal carcinoma through regulation of AKT\/NF-\u03baB\/mTOR and ERK1\/2 signaling pathways","volume":"83","author":"Zhang","year":"2016","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.neuropharm.2026.110887_bib51","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1096\/fj.06-7703com","article-title":"Amyloid beta oligomers induce impairment of neuronal insulin receptors","volume":"22","author":"Zhao","year":"2008","journal-title":"Faseb j"}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390826000602?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390826000602?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T04:35:00Z","timestamp":1779251700000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390826000602"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":51,"alternative-id":["S0028390826000602"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2026.110887","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fisetin targets multiple signaling pathways to suppress microglia-mediated neuroinflammation and cognitive decline in Alzheimer's disease","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2026.110887","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"110887"}}